W. Schröder

发表

Intron 22 of factor VIII gene--a hot spot for structural aberrations causing severe hemophilia A.

F. Herrmann, M. Wehnert, W. Schröder, 1996, Blood.

Epidemiology of Factor V Leiden Mutation in Various Populations: Northeastern Germany, Poland, Argentina, Venezuela, Costa Rica and India

S. Lopaciuk, F. Herrmann, W. Schröder, 1998 .

Predictive genetic testing of at-risk relatives requires analysis of all CCM genes after identification of an unclassified CCM1 variant in an individual affected with cerebral cavernous malformations

U. Felbor, W. Henn, J. Viera, 2013, Neurosurgical Review.

New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update

N. Lévy, D. Amor, V. Cormier-Daire, 2013, European Journal of Human Genetics.

Prevalence of eight molecular markers associated with thrombotic diseases in six Amerindian tribes and two African groups of Costa Rica

R. Grimm, K. Wulff, F. Herrmann, 2004, American journal of human biology : the official journal of the Human Biology Council.

Factor V Leiden, Prothrombin Gene G20210A Variant, and Methylenetetrahydrofolate Reductase C677T Genotype in Young Adults With Ischemic Stroke

H. Kwiecinski, J. Windyga, S. Lopaciuk, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Increased Resistance to activated Protein C and Protein C Deficiency in the same Family

S. Hutschenreiter, L. Kochhan, F. Herrmann, 2003 .

Molecular analysis of FVIII gene in severe HA patients of Costa Rica.

J. Oldenburg, A. Pavlova, K. Wulff, 2010, Hamostaseologie.

Reply to the letter by Kling et al.

F. Herrmann, M. Wehnert, W. Schröder, 1992, Human Genetics.

World distribution of factor V Leiden mutation

P. Reitsma, P. Morel, J. Jespersen, 1996, The Lancet.

High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors

A. Ferbert, U. Felbor, C. Fauth, 2014, Molecular genetics & genomic medicine.

Prevalence of Molecular Risk Factors FV Leiden, FV HR2, FII 20210G>A and MTHFR 677C>T in Different Populations and Ethnic Groups of Germany, Costa Rica and India

R. Grimm, F. Herrmann, G. Jiménez-Arce, 2001 .

Prevalence of Common Mutations and Polymorphisms of the Genes of FII, FV, FVII, FXII, FXIII, MTHFR and ACE — Identified As Risk Factors for Venous and Arterial Thrombosis — in Germany and Different Ethnic Groups (Indians, Blacks) of Costa Rica

R. Grimm, K. Wulff, F. Herrmann, 2001 .

Characterization of a Mutation in Exon 1 of the FVII Gene — a Case of RNA Editing?

G. Auerswald, K. Wulff, F. Herrmann, 2008 .

Common polymorphisms and cardiovascular factors in patients with myocardial infarction of Costa Rica.

K. Wulff, F. Herrmann, W. Schröder, 2014, Revista de biologia tropical.

High Prevalence of FVHR2 Polymorphism in Costarician Indians who Have no FVL

R. Grimm, F. Herrmann, G. Jiménez-Arce, 2001, Thrombosis and Haemostasis.

Diagnostic Single Gene Analyses Beyond Sanger

U. Felbor, M. Rath, W. Schröder, 2017, Hämostaseologie.

Structural gene aberrations in mucopolysaccharidosis II (Hunter)

J. Hopwood, F. Herrmann, M. Wehnert, 1992, Human Genetics.

Carrier detection of Hunter syndrome (MPS II) by biochemical and DNA techniques in families at risk.

L. Petruschka, J. Hopwood, F. Herrmann, 1993, Journal of medical genetics.

Mutations of the iduronate‐2‐sulfatase (IDS) gene in patients with hunter syndrome (mucopolysaccharidosis II)

K. Wulff, F. Herrmann, M. Wehnert, 1994, Human mutation.

Large-scale screening for factor V Leiden mutation in a north-eastern German population.

K. Wulff, F. Herrmann, M. Wehnert, 1996, Haemostasis.

Prevalence of factor V Leiden mutation in various populations

S. Lopaciuk, F. Herrmann, W. Schröder, 1997, Genetic epidemiology.

The FXIIIVal34Leu, common and risk factors of venous thrombosis in early middle‐age Costa Rican patients

K. Wulff, F. Herrmann, G. Jiménez-Arce, 2007, Cell biochemistry and function.

Factor V Variants — FV Leiden, FV R2 Polymorphism (ex 13), FV Ddel Polymorphism (int 16) - Risk Factors for Venous Thrombosis? Results of a Pilot Study

R. Grimm, F. Herrmann, W. Schröder, 2001 .

Characterization of a Mutation in the 5′ Flanking Region and a Novel IVS7 Splice site Mutation in a Patient with Severe FVII Deficiency

R. Grempler, A. Ruiz-Sáez, K. Wulff, 2007 .

Characterization of Three Novel Mutations in the Sodium Binding Site of Coagulation Factor X

K. Wulff, F. Herrmann, W. Schröder, 2007 .

Molecular Analysis of Hemophilia B: »Greifswald Registry FIX Deficiency (Hemophilia B)«

K. Wulff, F. Herrmann, W. Schröder, 2003 .

Polymorphisms in FV Gene associated with FV Deficiency — First Results

F. Herrmann, W. Schröder, 2003 .

Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopenia.

A. Greinacher, F. Herrmann, P. Eichler, 2003, Pharmacogenetics.

Twenty‐five novel mutations of the factor IX gene in haemophilia B

F. Herrmann, M. Wehnert, W. Schröder, 1995, Human mutation.

Molecular diagnosis of hemophilia A and B. Report of five families from Costa Rica.

K. Wulff, F. Herrmann, G. Jiménez-Arce, 2014, Revista de biologia tropical.

Genomic Diagnosis of Hemophilia A in Hungarian Patients

H. Losonczy, F. Herrmann, W. Schröder, 2001 .

Identification of a novel large F9 gene mutation—An insertion of an Alu repeated DNA element in exon e of the factor 9 gene

K. Wulff, F. Herrmann, H. Gazda, 2000, Human mutation.

Diagnostic Single Gene Analyses Beyond Sanger

U. Felbor, M. Rath, W. Schröder, 2017, Hämostaseologie.